Author name: R A

The nuclear medicine and radiopharmaceutical manufacturing market

Health & Safety / /

Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”   The report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals. In addition, the study features an in-depth analysis, highlighting the capabilities […]

The nuclear medicine and radiopharmaceutical manufacturing market Read More »

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030

Health & Safety / /

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”   Over the years, various technological advancements, such as antibody engineering for site-specific conjugation and enhanced pharmacokinetic and pharmacodynamic properties, have paved the way for antibody drug conjugates (ADCs) to be recognized as potent therapies

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030 Read More »

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies

Health & Safety / /

Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies Read More »

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030

Health & Safety / /

  Roots Analysis is pleased to announce the publication of its recent study, titled, “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”.   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of such

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030 Read More »

The ADC Cytotoxic Payloads / Warheads market is anticipated to grow at a CAGR of 12.4% till 2030

Health & Safety / /

Roots Analysis has announced the addition of “ADC Payloads Market, 2021-2030” report to its list of offerings.   Given the fact that ADCs are highly potent cytotoxic molecules, the manufacturing of ADCs requires elaborate and advanced technical capabilities and highly potent chemical substances. Specifically, the multi-step process of production of cytotoxic payloads, which are complex

The ADC Cytotoxic Payloads / Warheads market is anticipated to grow at a CAGR of 12.4% till 2030 Read More »

The biopharmaceutical excipient manufacturing market is projected to grow at an annualized rate of 5.8%

Health & Safety / /

Roots Analysis has announced the addition of “Biopharmaceutical Excipient Market” report to its list of offerings   Owing to the highly complex and capital-intensive manufacturing processes of biopharmaceutical excipients, many contemporary biologic developers prefer to rely on CMOs for the supply of GMP grade excipients. In order to cater to the growing demand for biopharmaceutical

The biopharmaceutical excipient manufacturing market is projected to grow at an annualized rate of 5.8% Read More »

The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030

Health & Safety / /

Roots Analysis has announced the addition of “Soft Tissue Sarcoma: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma Market, 2021-2030” report to its list of offerings.   Soft tissue sarcoma is a rare form of cancer that usually originates in soft / connective tissues and most commonly affects the abdomen, arms, head, legs, neck and trunk of

The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030 Read More »

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market

Health & Fitness / /

  The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity   Roots Analysis has announced the addition of “Cell Therapy Manufacturing market (3rd Edition), 2019 – 2030” report to its

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market Read More »

The synthetic lethality-based drugs and targets market

Health & Safety / /

Roots Analysis is pleased to announce the publication of its recent study, titled, “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”.   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of such compact

The synthetic lethality-based drugs and targets market Read More »

The proteome profiling services market is projected to be worth USD 16 billion by 2030

Health & Safety / /

Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this

The proteome profiling services market is projected to be worth USD 16 billion by 2030 Read More »